TRIF antibody was raised against a peptide corresponding to 14 amino acids near the C-terminus of human TRIF. The immunogen is located within the last 50 amino acids of TRIF.
Conjugation:
Unconjugated
Alternative Names:
IIAE6,MyD88-3,proline-rich, vinculin and TIR domain-containing protein B,PRVTIRB,putative NF-kappa-B-activating protein 502H,TICAM-1,TIR domain containing adaptor inducing interferon-beta,TIR domain-containing adapter molecule 1,TIR domain-containing adapter protein inducing IFN-beta,toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta,TRIF.
Involved in innate immunity against invading pathogens. Adapter used by TLR3 and TLR4 (through TICAM2) to mediate NF-kappa-B and interferon-regulatory factor (IRF) activation, and to induce apoptosis. Ligand binding to these receptors results in TRIF recruitment through its TIR domain. Distinct protein-interaction motifs allow recruitment of the effector proteins TBK1, TRAF6 and RIPK1, which in turn, lead to the activation of transcription factors IRF3 and IRF7, NF-kappa-B and FADD respectively.
